Potential survival benefit and early recovery from organ dysfunction with polymyxin B hemoperfusion: perspectives from a real-world big data analysis and the supporting mechanisms of action

BACKGROUND: Endotoxin (ET) removal therapy with polymyxin B-immobilized fiber column hemoperfusion (PMX-HP) has been used for the treatment of septic shock. Some observational studies reported clinical benefits, particularly in specific subgroups of patients. However, larger randomized controlled tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Shoji, Hisataka, Ferrer, Ricard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207853/
https://www.ncbi.nlm.nih.gov/pubmed/37386673
http://dx.doi.org/10.1186/s44158-022-00056-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207853/
https://www.ncbi.nlm.nih.gov/pubmed/37386673
http://dx.doi.org/10.1186/s44158-022-00056-5

Ejemplares similares